Discover how Evelo’s EDP1815 may prevent the progression of COVID-19.
Learn More
Evelo Biosciences Announces New Clinical Candidate in Oncology and Presents Additional Interim Data from Phase 1/2 Clinical Trial of EDP1503 in Patients with Triple-Negative Breast Cancer
